NGM Biopharmaceuticals, Inc. EBITDA 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. ebitda from 2019 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| NGM Biopharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-155 |
| 2022 | $-162 |
| 2021 | $-111 |
| 2020 | $-97 |
| 2019 | $-43 |
| 2018 | $2 |
| 2017 | $-11 |
| NGM Biopharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-30 |
| 2023-09-30 | $-32 |
| 2023-06-30 | $-42 |
| 2023-03-31 | $-51 |
| 2022-12-31 | $-39 |
| 2022-09-30 | $-48 |
| 2022-06-30 | $-45 |
| 2022-03-31 | $-31 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $-26 |
| 2021-06-30 | $-34 |
| 2021-03-31 | $-26 |
| 2020-12-31 | $-26 |
| 2020-09-30 | $-28 |
| 2020-06-30 | $-24 |
| 2020-03-31 | $-19 |
| 2019-12-31 | $-16 |
| 2019-09-30 | $-11 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $15 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-3 |
